Post Pandemic Obesity Posing a New Challenge

Translate to Spanish or other 102 languages!

Nearly two years into fighting COVID-19, we may have learned how to build our immunity but experts say we have unmasked another killer, obesity.  Newswise Image
Nearly two years into fighting COVID-19, we may have learned how to build our immunity but experts say we have unmasked another killer, obesity.  Newswise Image

Mega Doctor News

- Advertisement -

by Hackensack Meridian Health

Nearly two years into fighting COVID-19, we may have learned how to build our immunity but experts say we have unmasked another killer, obesity. 

“With so many people working from home and living a much more sedentary lifestyle, obesity has been steadily on the rise, “said Hans Schmidt, MD, chief, Bariatric Surgery at Hackensack University Medical Center. 

- Advertisement -

In fact, new data from the Centers for Disease Control and Prevention showed 16 states now have obesity rates of 35% or higher. That’s an increase of four states — Delaware, Iowa, Ohio and Texas — in just one year.

“Obesity is a leading risk factor for almost every serious disease from diabetes and heart disease to cancer and even COVID-19,” explained Dr. Schmidt. 

So, it may come as no surprise that interest in bariatric surgery is also on the rise. “At one point during the pandemic, it was estimated that 78% of hospitalized COVID-19 patients were obese or overweight and this had a major impact, people realized there was a correlation and were afraid,” explained Dr. Schmidt.

Emerging research may now explain why. A new, non-peer reviewed study found that COVID-19 may infect fat cells directly. The news may suggest that overweight and obese people may be at increased risk for severe disease and long COVID.

- Advertisement -

Today, Dr. Schmidt’s office is seeing a rise in people interested in learning more about weight loss options, including bariatric surgery. 

Beyond weight loss, new studies show bariatric surgery boosts life expectancy, reduces pressure inside the skull, lowers the risk of liver disease, COVID-19  and is effective at improving vascular outcomes.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

STC opens Wellness Center at Health Science Professions Campus

South Texas College recently inaugurated a new Wellness Center at its Health Science Professions Campus in McAllen, giving students, faculty and staff free access to a space designed to support both physical and mental well-being.
- Advertisement -